Jim Cramer Reacts to the Gilead Sciences-Kite Pharma Acquisition
Gilead is acquiring Kite Pharma.
Gilead Sciences (GILD) - Get Report agreed to acquire Kite Pharma (KITE) for $11.9 billion on Monday, sending shares of both stocks higher.
Watch all of Jim Cramer's latest videos, right here:









